Quest Diagnostics Incorporated

NYSE:DGX

Sector

🏥 Health Care

Industries

💻 Telehealth

🩺 Medical Instruments

Location

United States

Market Cap

USD 20.03 B

Share Price

USD 179.43

Avg Daily Volume

1,324,738

Change (1 day)

-0.19%

Change (1 year)

29.83%

Change (YTD)

18.94%

Quest Diagnostics Incorporated Enterprise Value to EBITDA (EV/EBITDA) on June 20, 2025: 13.36

Quest Diagnostics Incorporated Enterprise Value to EBITDA (EV/EBITDA) is 13.36 on June 20, 2025, a 15.24% change year over year. EV/EBITDA ratio compares the enterprise value to the EBITDA; lower suggests more favorable company valuation.

Quest Diagnostics Incorporated 52-week low Enterprise Value to EBITDA (EV/EBITDA) is 13.63 on June 20, 2025, which is 2.02% above the current Enterprise Value to EBITDA (EV/EBITDA).
Quest Diagnostics Incorporated 52-week low Enterprise Value to EBITDA (EV/EBITDA) is 11.42 on June 20, 2025, which is -14.47% below the current Enterprise Value to EBITDA (EV/EBITDA).
Quest Diagnostics Incorporated average Enterprise Value to EBITDA (EV/EBITDA) for the last 52 weeks is 12.67.

Daily

From:

To:

Zoom:

Key data

Date	Enterprise Value to EBITDA (EV/EBITDA)	Free Cash Flow Yield	Dividend Yield	Market Capitalization

NYSE: DGX

Quest Diagnostics Incorporated

CEO	Mr. James E. Davis
IPO Date	Dec. 17, 1996
Location	United States
Headquarters	500 Plaza Drive
Employees	55,000
Sector	🏥 Health Care
Industries Telehealth 🩺 Medical Instruments

Description

Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to patients, clinicians, hospitals, independent delivery networks, health plans, employers, direct contract entities, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile paramedics, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians robust information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.